Connect with us

Local

Sexual assault may be dropped in Wone murder case

The lead prosecutor in the Robert Wone murder case startled courtroom
 spectators last

Published

on

The lead prosecutor in the Robert Wone murder case startled courtroom
 spectators last week when he said the government would likely drop its theory that Wone was immobilized by a paralytic drug and
 sexually assaulted before being stabbed to death in the Dupont Circle
 home of three gay men.

The disclosure by Assistant U.S. Attorney Glenn Kirschner at 
a D.C. Superior Court hearing March 12 drew visible sighs of relief from 
defendants Joseph Price, Victor Zaborsky and Dylan Ward. Price gave a
 thumbs-up signal to his attorney, Bernard Grimm.

“This appears to be a major victory for the defense,” said D.C.
 attorney Dale Sanders, who practices criminal law in the District.

Sanders said that by withdrawing its earlier contention that Wone was
 sexually assaulted and drugged, prosecutors would make it easier for
 the defense to promote their own contention that an unidentified 
intruder killed Wone after entering the home of the three gay men 
through a rear door.

The men have been indicted on charges of obstruction of justice,
 conspiracy to obstruct justice, and evidence tampering in connection
 with the August 2006 murder. Authorities have yet to charge anyone 
with the murder itself. The trial is scheduled to begin May 10.

Kirschner told D.C. Superior Court Judge Lynn Leibovitz that 
prosecutors were still considering introducing other evidence at trial 
considered highly controversial: a collection of S&M sex toys seized by 
police from Ward’s bedroom, which prosecutors have said was located
 across the hall from where Wone was found stabbed in a second-floor
 guest bedroom.

Wone, a prominent Washington attorney, was friends with the three men 
and spending the night at their home after working late in his
 downtown office, the men and members of Wone’s family have said. Wone
 was married to a woman, and his family members said he was straight.

Leibovitz said she had yet to see sufficient evidence presented by 
prosecutors to justify the introduction of the “devices” at trial. She 
noted that defense attorneys presented arguments as to why such 
evidence was not relevant to the case and how it would be prejudicial to the jury.

She directed prosecutors to file a motion before April 2 explaining 
their rationale for introducing such evidence and said she would rule
 on its admissibility at that time.

Leibovitz denied a motion by the defense asking the court to order
 prosecutors to release more details surrounding their evidence and 
theories in the case, saying the government has complied with all
 “discovery” requirements for informing the defense of its evidence.

Last week’s hearing followed a court motion filed by prosecutors in
 February seeking permission to introduce evidence at trial that Price,
 Zaborsky and Ward engaged in possible criminal conduct not 
identified in the charges pending against them. Some of the alleged
 conduct cited in the court filing pertained to the use of S&M-related
 restraining devices as well as devices used to administer electrical
 shocks to a person’s genitals.

“Are you planning to tell the jury that he was sexually assaulted, 
restrained,” that sex toys were used on him and he was injected with 
something? Leibovitz asked Kirschner.

“We’re moving away from the sexual assault proof,” Kirschner replied. But he said prosecutors still planned to offer some evidence that
 “restraints” were found in Ward’s bedroom.

In response to another assertion made by prosecutors in their February
 court filing — that “the killer is someone known to and being
 protected” by Price, Zaborsky and Ward — Leibovitz asked Kirschner,
” Do you plan to say one or all of these men killed Wone?”

“Not directly,” Kirschner replied.

He said prosecutors also plan to present evidence from the autopsy of
 needle marks on Wone’s body, including marks he noted the government’s
 medical experts would show were not made by emergency medical 
technicians who arrived at the scene and tried to revive Wone.

Kirschner disclosed at the hearing that he had submitted a letter to 
the defense earlier in the day, which he also filed with the court,
 saying that the government obtained new information from medical 
experts that appeared to raise doubts over whether Wone had been
 sexually assaulted or immobilized by a paralytic drug.

Authorities first raised that theory 
in a lengthy criminal complaint filed at the time police brought
 criminal charges against the three men for obstruction of justice and
 evidence tampering.

The complaint cited an autopsy finding showing that Wone suffered
 three surgical-like, clean stab wounds in the chest and abdomen that 
could only have occurred if he were lying completely still. The
 complaint, and subsequent arguments by prosecutors, claimed that a 
person being stabbed would be expected to recoil in pain or move in a
 defensive way, causing the wounds to be jagged or distorted.

Prosecutors said a paralytic drug must have been administered to
 Wone to render him immobile, but they acknowledged that the autopsy 
and subsequent chemical tests could not find traces of such a drug in 
Wone’s body. They argued that the type of anesthesia-like drug in
 question usually dissipates quickly and cannot be detected in tests.

But defense attorneys say in their own court filings that they
 would present expert witnesses to show that such drugs are detectable
 in tests, and the government’s inability to detect such a drug shows 
it was never administered.

According to prosecutors, the sexual assault theory was based on 
another finding in the autopsy that traces of Wone’s semen were 
found inside his rectum. The defense later argued that its own experts 
would show that the semen had no sperm cells, indicating it was 
secreted naturally by the body after Wone died, as muscles relax during 
the post mortem processes.

Sanders said that although the apparent decision by prosecutors to put aside their earlier sexual assault and paralytic drug theory is a blow to the prosecutors’ case, other evidence obtained against the three men remains significant and strong.

He noted, among other things, that investigators found traces of blood in the lint trap of the men’s clothes dryer and in a drain outside the house; findings by evidence technicians that someone cleaned the crime scene by attempting to wipe blood spattered near the body; and that the bloody kitchen knife that the men said they found near Wone’s body bore fibers from a towel, indicating to evidence experts that Wone’s blood was wiped onto knife blade by someone, with another knife likely used to kill Wone.

Authorities also have said Wone appeared to have been dead a significant period of time before Zaborsky called 911 to report a stabbing; and rescue workers reported finding very little blood on Wone’s chest and body, indicating that someone cleaned the body before police and rescue workers were called, according to the police affidavit.

“They won this battle, but the war doesn’t look good for them,” Sanders said. “You can’t lose track of the big picture, which doesn’t look good for these guys.”

Advertisement
FUND LGBTQ JOURNALISM
SIGN UP FOR E-BLAST

District of Columbia

Physician: addiction doesn’t always look the way you think it does

Yngvild Olsen headed HHS’s Center for Substance Abuse Treatment during Biden-Harris administration

Published

on

Dr. Yngvild Olsen (Photo courtesy of Olsen)

Many people think the telltale signs of drug addiction include sweating and vomiting. But a prominent addiction medicine physician says the best signals aren’t always so visible. 

Dr. Yngvild Olsen says more accurate signs come from the brain, specifically the compulsion to keep using drugs, including opioids, despite damage to education, career and relationships. 

While it may be harder to understand the true nature of drug addiction, it’s never been more important because of the increased fatality risk of even microscopic amounts of fentanyl, which can be found in many illegal drugs. 

Olsen, who headed the Center for Substance Abuse Treatment at the Department of Health and Human Services in the Biden-Harris administration, has worked in addiction treatment for more than two decades. She is now a healthcare advisor with the law and professional consulting firm Manatt, Phelps & Phillips and a physician at the Institute for Behavior Resources/Reach Health Services in Baltimore. 

Olsen met with Youthcast Media Group to discuss her career, the opioid epidemic and what to know about fentanyl. The physician, a graduate of Harvard Medical School and the John Hopkins Bloomberg School of Public Health, cited her field experiences as key in shaping her perspective on addiction treatment and recovery. This interview is edited for clarity and length. 

What made you believe this work in addiction treatment is important?

I had a couple of experiences really early on in my career that very significantly shaped my interest in addiction and addiction medicine, and my belief that I had a role, and that I could really help people get better from that disease. So the first was during the summer between my first and second year in medical school. I spent the summer on the Eagle Butte and Pine Ridge reservations in South Dakota and really saw firsthand just the devastating impact that substance use — in that case, alcohol — had on not only individuals, but their families and whole communities, and just how profound that impact had been for people who had lost their lives, who had lost family members, who had physically, emotionally and spiritually negative impacts of just feeling very hopeless and and trying to find solace in their substance use, particularly their alcohol use, and doing that without really finding it. I think that was really the lesson that experience taught me. 

What did you learn about treatment practices during your medical education? How was that helpful to your career?

When I was a resident in general primary care at Boston Medical Center, I was really fortunate to have a group of mentors who also were general internists, like I was training to be, who were very interested and focused on medical education and research in substance use. And so they modeled for me many of the interactions that we had with patients. I got to do a research study with one of them looking at smoking cessation among people with opiate use disorder, taking methadone. And really importantly, I got to spend a month with one of them at the Boston City Public Health Department’s Opioid Treatment Program, or what some people call a methadone clinic, because he was their medical director. I got to see people recover, and who had recovered, who had gotten their lives back together, gotten their families back together, had new families (or) businesses. It was unbelievably helpful to see that people could recover, that they did recover, and that I, as a physician, could be part of their treatment. I saw people get better, and recover, with medications like methadone and buprenorphine, and other services designed individually for them. That was really helpful and kind of a big eye-opening moment for me.

What factors contribute to addiction and why is it considered a complex disease?

People come into treatment for their addiction — or when they’re not in treatment, but are in an emergency department or on the street — with a lot of shame. They have a lot of shame about this disease that they have, that for so long, they were told, ‘Well, you know, you should just stop. Why can’t you just stop?’ Well, we know that addiction is a disease. It’s a complex disease that has lots of different factors related to it. So there’s a big genetic component that combines with environmental factors and other risk factors. For example, people have what’s called adverse childhood experiences. Some of these are if they grow up with lots of physical or sexual abuse or emotional abuse or have parents who are in jail. That’s really traumatic and so all those childhood experiences that increase stress are a big risk factor. 

What is the easiest opioid to get addicted to?

It used to be heroin. That was a big problem, particularly in the Northeast and other parts of the country. That shifted to prescription opioids, beginning around the year 2000. So for about 10 years, it was really prescription opioids that were a big problem — people misusing them. And then it switched back to heroin. And then in about 2015, fentanyl came on the scene, and that really changed the game, given just how unbelievably potent fentanyl is, so it doesn’t take a lot to cause an overdose. Now there are all those other synthetic opioids, like the orphines and nitazenes and all those combinations of other substances, but fentanyl is really what’s still kind of driving a really big part of the overdose crisis.

Do LGBTQ individuals face heightened challenges when battling addictions? How do addiction specialists like you account for those challenges?

We certainly know that the prevalence of overdose and the challenges of substances is higher in the LGBTQ+ community. Where I see patients, we did a big LGBTQ+ training and had a grant to specifically provide services to that population. Where we were located, in Baltimore City, there is a big transgender community not that far from us. Particularly in the LGBTQ+ population, they have multiple stigmas. So it just compounds multiple stressors. And stress is a risk factor for substance use, and particularly a risk factor for recurrence of a substance use disorder. And so when you have all these negative factors building up in people, that can make it that much more challenging for people to find the services that they find meaningful and that are welcoming and supportive of them. So we tried very hard — and we still do — to make sure that we are a welcoming and safe space, because I think it is that safety that is really paramount.

What advice would you give someone worried about a friend or family member’s substance use?

There are two things. One is: I would talk to that person about your concerns and how that person’s personality changes or their behavior changes when they’re using or in withdrawal, and how that might be impacting their health and how they’re feeling. And then second: you can let them know that there are actual treatments that are really helpful, that can make them feel better and that can help them get back to who they were before they started using. It’s important not to be accusatory because … [people] have a lot of shame already, and so when somebody starts accusing them, that shame just gets worse. And a lot of times, people who have a substance use disorder or are using opioids won’t necessarily agree that they have a problem when you first start to talk to them. But talk to them again every time something happens and say, ‘I’m really worried about you because this now has happened and I see it as being tied to your substance use.’ And let them know that there are people who can help and that they could actually feel a lot better.

This work is part of a partnership between the Washington Blade Foundation and Youthcast Media Group, funded in part through a FY26 Community Development Grant from the Office of D.C. Mayor Muriel Bowser. Adrian Malone is a senior at Bard High School Early College DC, one of Youthcast Media Group’s journalism class partners. Shreya Jyotishi, YMG assistant manager of content and programming, is a former Washington Blade intern and 2026 graduate of American University.

Continue Reading

District of Columbia

Bet Mishpachah participates in D.C. Oct. 7 commemoration ceremony

Wednesday marked three years since Hamas attacked Israel

Published

on

Bet Mishpachah Executive Director Joshua Maxey speaks at an Oct. 7 commemoration ceremony at Washington Hebrew Congregation in D.C. on Oct. 7, 2026. (Photo courtesy of Joshua Maxey)

Bet Mishpachah Executive Director Joshua Maxey on Wednesday was among those who spoke at a ceremony in D.C. that marked the third anniversary of the Oct. 7 attack in Israel.

The Jewish Federation of Greater Washington hosted the ceremony that took place at the Washington Hebrew Congregation in Northwest D.C. Bet Mishpachah is the city’s LGBTQ synagogue.

“It was a deeply moving evening, especially hearing the stories of people who knew those who were murdered and those who survived and experiencing music that gave a voice to grief and hope,” Maxey told the Washington Blade.

Hamas militants on Oct. 7, 2023, killed roughly 1,200 people, including upwards of 360 partygoers at the Nova Music Festival near Re’im, a kibbutz that is a couple miles from the Gaza Strip, when it launched its surprise attack on Israel. The militants also kidnapped more than 200 people.

The Hamas-controlled Gaza Health Ministry says Israeli forces have killed more than 74,000 people in the enclave since Oct. 7.

The International Criminal Court in 2024 issued arrest warrants for Israeli Prime Minister Benjamin Netanyahu; former Israeli Defense Minister Yoav Gallant; former Hamas leader Yahya Sinwar; Mohamed Diab Ibrahim al-Masri, the head of Hamas’s military wing known as the Qassam Brigades; and Ismail Haniyeh, chair of the Hamas Political Bureau, after it accused them of committing war crimes and crimes against humanity in Gaza and Israel.

The Israeli government has strongly denied it has committed genocide in Gaza.

An Israeli airstrike on a compound in Khan Younis, a city in southern Gaza, on July 13, 2024, killed killed Deif, one of the alleged Oct. 7 masterminds. Israel less than three weeks later assassinated Haniyah in Tehran, the Iranian capital. Israel Defense Forces soldiers on Oct. 16, 2024, killed Sinwar in Rafah, a city in southern Gaza.

Hamas last October released the remaining hostages in Gaza as part of a ceasefire agreement that President Donald Trump helped broker. Israel has continued to conduct airstrikes and other military operations in Gaza since the official suspension of hostilities took effect.

“For Bet Mishpachah, it was especially meaningful to lift up the names of LGBTQ+ people, those whose identities we know and those whose stories may never be fully known, who were murdered, and to honor the LGBTQ+ survivors whose resilience continues to inspire us,” said Maxey, referring to his participation in Wednesday’s ceremony. “Emily Damari’s story is particularly poignant: while held hostage, she had to hide the fact that she was gay because she feared that revealing her identity to her captors could put her life at even more risk. Yet, she survived.”

“Her story, like so many others, reminds us of the extraordinary courage it takes simply to remain human in the face of hatred,” he added. “May we continue to remember and to mourn, to honor, and to work toward a future rooted in peace and hope.”

Continue Reading

Virginia

Campaign urges Virginia High School League to reverse stance on trans athletes

Equality Arlington and other advocacy groups behind ‘Right 2 Play’ VA’ initiative

Published

on

(Inked Pixels via Bigstock photo)

Virginia advocacy groups have launched a campaign that urges the Virginia High School League to once again allow student athletes to compete on sports teams that correspond with their gender identity.

Equality Arlington on Sept. 16 published an article about the “Right 2 Play VA” campaign. Amy, a group representative, spoke about the initiative with the Washington Blade.

“The primary goal is to reverse the Virginia High School League’s discriminatory ban on allowing transgender girls to play on girls’ sports and replace it with a policy that is fair for all students.” they said.

The Virginia High School League in 2025 announced the policy, which reversed a previous position in support of transgender and nonbinary athletes. The 2025 policy coincided with President Donald Trump’s executive order — “Keeping Men Out of Women’s Sports” — that threatened to “rescind all funds from educational programs that deprive women and girls of fair athletic opportunities, which results in the endangerment, humiliation, and silencing of women and girls.”

The Arlington Gender Identity Alliance, Equality Virginia, and the American Civil Liberties Union of Virginia have also joined the “Right 2 Play VA” campaign.

“We had a policy in Virginia for 12 years that allowed transgender girls to play on girls’ sports teams, and we had not one instance — not one instance — that was brought forward demonstrating an unfair advantage or any type of safety concern,” said Amy. 

Amy then discussed what they described are the benefits of trans youth playing sports.

“There are physical benefits. There are mental health benefits. There are community and social development benefits, and those are all well documented,” they said. “All kids should have the right to benefit from playing youth sports. We are talking about kids. We are talking about youth. We are not talking about Olympians. We are not talking about Division One college athletes. We are talking about kids in Virginia, and because the benefits of sports are so well documented, we think that every kid should have the ability to play sports.”

Continue Reading

Popular